Benefis Sletten Cancer Institute — Great Falls, Montana

Benefis Sletten Cancer Institute is a clinical research site located in Great Falls, Montana, United States 59405.

Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.

Benefis Sletten Cancer Institute has participated in 275 clinical trials with 225 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Great Falls

Browse all research sites in Montana · View every site in Great Falls

Sponsor Feasibility Report

Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Benefis Sletten Cancer Institute?

Benefis Sletten Cancer Institute has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Benefis Sletten Cancer Institute conducted?

Benefis Sletten Cancer Institute has 275 clinical trials on record, with 225 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Benefis Sletten Cancer Institute accredited by Crixeo Clinical Trials?

Benefis Sletten Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Benefis Sletten Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.